Group One Trading’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.83M Sell
347,100
-402,400
-54% -$3.65M 0.01% 1762
2025
Q4
$5.04M Sell
749,500
-341,200
-31% -$2.57M 0.01% 1476
2025
Q3
$9.46M Sell
1,090,700
-141,800
-12% -$1.1M 0.02% 947
2025
Q2
$7.76M Buy
1,232,500
+485,200
+65% +$3.21M 0.02% 996
2025
Q1
$4.79M Sell
747,300
-681,400
-48% -$5.63M 0.01% 1109
2024
Q4
$11.5M Buy
1,428,700
+198,600
+16% +$1.91M 0.03% 624
2024
Q3
$15.5M Buy
1,230,100
+67,100
+6% +$866K 0.04% 383
2024
Q2
$14.7M Sell
1,163,000
-150,700
-11% -$1.52M 0.06% 287
2024
Q1
$6.28M Sell
1,313,700
-912,800
-41% -$4.23M 0.02% 689
2023
Q4
$10.7M Buy
2,226,500
+1,030,400
+86% +$6.31M 0.03% 659
2023
Q3
$8.66M Buy
1,196,100
+385,500
+48% +$3.08M 0.03% 598
2023
Q2
$6.02M Buy
810,600
+345,300
+74% +$2.72M 0.02% 828
2023
Q1
$3.22M Buy
465,300
+76,400
+20% +$703K 0.01% 1146
2022
Q4
$4M Sell
388,900
-45,900
-11% -$810K 0.01% 1302
2022
Q3
$7.91M Buy
434,800
+55,700
+15% +$2.41M 0.02% 867
2022
Q2
$19.5M Sell
379,100
-8,900
-2% -$461K 0.03% 490
2022
Q1
$28.6M Sell
388,000
-310,000
-44% -$27.6M 0.03% 451
2021
Q4
$99.9M Buy
698,000
+315,000
+82% +$54.1M 0.08% 148
2021
Q3
$79.4M Buy
383,000
+106,000
+38% +$23.4M 0.09% 157
2021
Q2
$58.8M Sell
277,000
-19,400
-7% -$3.55M 0.07% 217
2021
Q1
$53.7M Sell
296,400
-168,000
-36% -$33.5M 0.08% 189
2020
Q4
$51.8M Buy
464,400
+233,700
+101% +$24.8M 0.09% 179
2020
Q3
$25M Buy
230,700
+70,100
+44% +$8.54M 0.08% 210
2020
Q2
$13.4M Buy
160,600
+5,900
+4% +$226K 0.06% 348
2020
Q1
$2.1M Sell
154,700
-401,300
-72% -$3.4M 0.02% 1009
2019
Q4
$2.21M Sell
556,000
-30,300
-5% -$131K 0.02% 1213
2019
Q3
$2.94M Sell
586,300
-57,500
-9% -$315K 0.02% 917
2019
Q2
$3.77M Buy
643,800
+567,875
+748% +$4.47M 0.03% 685
2019
Q1
$837K Buy
75,925
+35,820
+89% +$1.13M 0.01% 1536
2018
Q4
$1.48M Buy
40,105
+2,610
+7% +$101K 0.01% 1225
2018
Q3
$1.41M Buy
37,495
+535
+1% +$15.1K 0.01% 1427
2018
Q2
$991K Sell
36,960
-13,395
-27% -$453K 0.01% 1737
2018
Q1
$2.12M Buy
50,355
+24,095
+92% +$968K 0.02% 972
2017
Q4
$651K Sell
26,260
-615
-2% -$15K ﹤0.01% 2045
2017
Q3
$613K Buy
26,875
+7,140
+36% +$160K 0.01% 1918
2017
Q2
$454K Buy
19,735
+3,930
+25% +$77.1K ﹤0.01% 2039
2017
Q1
$405K Sell
15,805
-5,740
-27% -$158K ﹤0.01% 1995
2016
Q4
$543K Sell
21,545
-8,070
-27% -$235K 0.01% 1709
2016
Q3
$1.23M Buy
29,615
+7,180
+32% +$927K 0.01% 1134
2016
Q2
$3.26M Buy
22,435
+3,785
+20% +$434K 0.04% 569
2016
Q1
$1.93M Sell
18,650
-2,595
-12% -$278K 0.03% 790
2015
Q4
$3.56M Buy
21,245
+3,200
+18% +$492K 0.04% 527
2015
Q3
$2.55M Buy
18,045
+9,790
+119% +$2.2M 0.04% 642
2015
Q2
$1.84M Sell
8,255
-2,805
-25% -$493K 0.03% 804
2015
Q1
$1.83M Buy
11,060
+2,435
+28% +$395K 0.03% 684
2014
Q4
$1.02M Sell
8,625
-10,770
-56% -$1.13M 0.02% 1063
2014
Q3
$1.62M Sell
19,395
-5,185
-21% -$469K 0.02% 812
2014
Q2
$2.27M Buy
24,580
+9,310
+61% +$818K 0.04% 623
2014
Q1
$1.38M Buy
15,270
+1,750
+13% +$196K 0.02% 856
2013
Q4
$1.38M Buy
13,520
+3,065
+29% +$217K 0.02% 891
2013
Q3
$661K Buy
10,455
+6,955
+199% +$392K 0.01% 1362
2013
Q2
$144K Buy
+3,500
New +$152K ﹤0.01% 2471

Other funds holding NVAX

Group One Trading's NVAX Position: Q1 2026 in Review

Group One Trading reduced its Novavax (NVAX) stake by 28% in Q1 2026, selling an estimated $1.2M and leaving 342,064 shares worth $2.78M. The position accounts for 0.01% of the portfolio, ranked #1775.

Group One Trading first reported a position in NVAX in Q2 2013 and has held it in 40 quarters since. The position peaked at $25.3M in Q2 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Group One Trading held 342,064 shares of Novavax worth $2.78M as of Q1 2026.
  • Group One Trading sold 132,513 Novavax shares in Q1 2026, an estimated $1.2M.
  • Novavax made up 0.01% of Group One Trading's portfolio in Q1 2026, its #1775 holding.
  • Group One Trading first reported a position in Novavax in Q2 2013 and has held it in 40 quarters since.
  • Group One Trading's Novavax position peaked at $25.3M in Q2 2021.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.